News | News By Subject | News by Disease News By Date | Search News

Hemorraghic News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Protein Design Labs, Inc. (PDLI) And Orphan Therapeutics, LLC Report Fast Track Designation For Terlipressin In Type 1 Hepatorenal Syndrome     4/21/2005
Baxter Healthcare Corporation (BAX) Assumes Marketing And Distribution Rights For Cangene Corporation's WinRho SDF In The U.S.     3/29/2005
Nuvelo, Inc. (NUVO) Phase 2 Clinical Trial Results Show Potential Of Alfimeprase To Restore Function In Occluded Central Venous Catheters     12/6/2004
FDA Grants ISTA Pharmaceuticals' (ISTA) Vitrase Five-Year Market Exclusivity     10/28/2004

News from Around the Web

Press Releases
Lupin (LUPN.BO) Bolsters US Brands Portfolio With Methergine Oral Tablets     4/29/2016
Hospira Announces U.S. Launch Of Generic Bivalirudin For Injection     7/17/2015
Remedium Technologies Receives FDA Clearance For Hemogrip Technology To Help Stop Bleeding     7/16/2015
NanoViricides, Inc. (NNVC.PK) Announces That DengueCide™ Has Received Orphan Drug Designation From the FDA     8/12/2013
Sangart, Inc. Initiates Phase 2b Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock     6/14/2011
NanoViricides, Inc. (NNVC.PK) Release: Anti-Dengue NanoViricides Achieve Significant Protection in Initial In Vivo Studies on Dengue Hemorrhagic Fever     6/21/2010
National Institute of Allergy, Infectious Disease To Test Tarvacin(TM) For Antiviral Potential     4/4/2005
Mitsubishi Pharma Corporation Launches Two Injections For Internal Hemorrhoid Scleotherapy     3/25/2005
ISTA Pharmaceuticals (ISTA) Submits Supplemental New Drug Application For Vitrase For Use As A Spreading Agent     8/2/2004
ISTA Pharmaceuticals (ISTA) Announces Vitrase Phase III Data Presented At Hawaiian Eye Meeting     1/30/2004
ViroPharma Incorporated (VPHM) Announces Advancements In Its Hemorrhagic Fever Virus Biodefense Program     12/18/2003

//-->